Submission of Voting Results along with Scrutinizer''s report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) held an Extra Ordinary General Meeting (EGM) on January 9, 2026, via video conferencing. Two resolutions were put to vote: (1) a Special Resolution to issue Equity Shares on a preferential basis, and (2) an Ordinary Resolution to confirm the appointment of Ms. Sridevi Belide (DIN: 10455373) as a Non-Executive Non-Independent Director. Both resolutions were passed with 100% votes in favour — 86 shareholders voted, casting 1,01,47,138 votes, representing 62.87% of total outstanding shares of 1,61,41,000. No votes were cast against either resolution, and the scrutinizer (Bharat Khaniwal & Co.) confirmed the results as valid.
The approval of the preferential share issue signals potential equity dilution for existing shareholders, as new shares will be issued to select parties at a determined price. The director appointment adds a new non-independent face to the board. Strong 100% approval on both items suggests promoter and participating public shareholders are aligned, though non-voting shareholders should monitor the terms of the preferential allotment closely.